Spectranetics Receives FDA Clearance for Cross-Pilot Product
Spectranetics Corp. has received clearance from the US Food and Drug Administration (FDA) for its Cross-Pilot laser support catheter. The product will be launched during the first quarter of 2009 within the US, Europe and Canada. The Cross-Pilot is a laser support catheter for the 0.9 Turbo Elite laser ablation catheter, and was designed to provide additional support for reaching distal lesions. The braid reinforced catheter construction and hydrophilic coating allow for better pushability through distal vessels and the angled tip allows for quicker access to branched anatomy. Cross-Pilot is currently offered in a 125-cm length and straight and angled tip configurations. Spectranetics is located in Colorado Springs, Colo., and manufactures the only excimer laser approved in the US, Europe and Japan for use in minimally invasive cardiovascular procedures.
- excimer laser
- A rare-gas halide or rare-gas metal vapor laser emitting in the ultraviolet (126 to 558 nm) that operates on electronic transitions of molecules, up to that point diatomic, whose ground state is essentially repulsive. Excitation may be by E-beam or electric discharge. Lasing gases include ArCl, ArF, KrCl, KrF, XeCl and XeF.
- The technology of generating and harnessing light and other forms of radiant energy whose quantum unit is the photon. The science includes light emission, transmission, deflection, amplification and detection by optical components and instruments, lasers and other light sources, fiber optics, electro-optical instrumentation, related hardware and electronics, and sophisticated systems. The range of applications of photonics extends from energy generation to detection to communications and...
MORE FROM PHOTONICS MEDIA